Investor Presentation
June 2021
DISCLAIMERS AND FORWARD-LOOKING STATEMENTS
This presentation includes express or implied statements that are not historical facts and are considered forward- looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future results of operations or of our financial information or state other forward-looking information. In some cases, you can identify forward-looking statements by the following words:
"may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue,"
"ongoing," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control, including, without limitation, statements about our future financial performance, including our revenue, cash flows, costs of revenue and operating expenses; our anticipated growth; our predictions about our industry; the impact of the COVID-19 pandemic on our business and our ability to attract, retain and cross-sell to healthcare provider clients. The forward-looking statements contained in this release are also subject to other risks and
uncertainties, including those more fully described in our filings with the Securities and Exchange Commission ("SEC"), including in our Annual Report on Form
10-K for the fiscal year ended January 31, 2021. The forward-looking statements in this presentation speak only as of the date on which the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this presentation to reflect events or circumstances after the date of this presentation or to reflect new information or the occurrence of unanticipated events, except as required by law.
2
OUR MISSION
To create a better, more engaging
healthcare experience
3
is Patient Intake
Who we are: Leading provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care
What we do: Enable healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care
How we do it: Software-as-a-Service (SaaS) platform to manage the patient intake process and an integrated patient payments solution for
secure processing of patient payments
~1,900 healthcare provider organizations
~$2.0B
patient payments processed in FY21
$149M
revenue in FY21
19% revenue growth in FY21
~$9B total addressable market
4
ATTRACTIVE INDUSTRY TAILWINDS
Wasteful | Increasing Patient | Increasing | Shift to Value-Based | Focus on |
Spending | Responsibility | Consumerism | Care Models | Personalized |
Healthcare Solutions |
- 1.2M intake staff represent $37B in annual spending
- $3.6T U.S. healthcare spend1
- $1.1T U.S. healthcare waste1
- ~$300B admin- related waste1
- $586B out-of- pocket spend by 2027
- HDHPs represent 46% of health plan market2
- Provider organizations collect only half of patient balances after initial visit
• | Demand for higher | • | Payment model | • | Need to directly |
quality care, cost | shift to incentivize | reach patients | |||
transparency, | value and quality | when making care | |||
shared decision | • | Requires high levels | decisions | ||
making and | |||||
of documentation, | • | Current marketing | |||
convenience | |||||
robust data, | strategies not as | ||||
• | 70%+ of patients | sophisticated | effective as | ||
use online reviews | payment-attribution | targeted outreach | |||
as first step in | capabilities and | ||||
physician search | substantive patient | ||||
engagement |
1 In 2018
2 As of the first half of 2018
5
Attachments
- Original document
- Permalink
Disclaimer
Phreesia Inc. published this content on 02 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 June 2021 07:32:06 UTC.